View Exam | PowerPak

1. Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment goals?

A. Dementia B. Gastroparesis C. Living in a group home D. Obesity

2. In The Diabetes in Aging Study, which of the following was NOT among the top 3 most common nonfatal comorbidities that led experts to modify treatment goals in older patients?

A. Acute hyperglycemic events B. Coronary artery disease C. Diabetes of long duration D. Hypoglycemia

3. At the time of diagnosis of diabetes, about how much beta-cell function is believed to be intact?

A. 100% B. 90% C. 75% D. <50%

4. Which of the following is CORRECT about sliding-scale insulin?

A. It combines basal insulin plus prandial insulin. B. It is the same as correction insulin. C. It uses rapid-acting insulin analogs rather than regular insulin to correct hyperglycemia while minimizing the risks of hypoglycemia. D. Its use should be discouraged because it is not physiologic in that it fails to provide basal or background insulin coverage.

5. If deciding to recommend the use of prandial insulin to intensify therapy in older patients, which of the following approaches would you choose to minimize the risk of hypoglycemia?

A. Basal-bolus therapy B. Basal-plus therapy with one injection of a rapid-acting insulin analog C. Premixed insulin (discontinue basal insulin) D. Addition of regular insulin to basal insulin

6. All of the following are features of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) EXCEPT:

A. May reduce the dose needed of basal insulin B. May result in weight loss or at least in no weight gain C. Similar efficacy to insulin without hypoglycemia risks D. Well tolerated with low risk of adverse effects

7. All of the following are CORRECT regarding postprandial hyperglycemia EXCEPT:

A. Dipeptidyl peptidase-4 (DPP-4) inhibitors target postprandial hyperglycemia. B. Loss of postprandial glycemic control precedes stepwise deterioration of fasting glucose with worsening diabetes. C. Postprandial hyperglycemia predominates at higher A1C levels. D. Postprandial hyperglycemia is linked with macrovascular complications.

8. Which of the following agents is NOT metabolized by the kidney and does not have dosing alterations in patients with renal impairment?

A. Exenatide B. Dulaglutide C. Glyburide D. Sitagliptin E. Canagliflozin

9. Which of the following is an example of a duplicative mechanism of action drug-drug interaction that should be brought to the attention of the prescribing clinician?

A. GLP-1 RA + DPP-4 inhibitor B. Metformin + GLP-1 RA C. Insulin + SGLT-2 inhibitor D. Metformin + thiazolidinedione

10. Which of the following is the most common cause of death for patients with T2DM that clinicians should be aware of when considering the adverse-effect profile of antihyperglycemic agents?

A. CV disease B. End-stage renal disease C. Nondiabetic ketoacidosis D. Stroke

Maintenance is scheduled for 08/28/2024 6:00 AM EST - 08/28/2024 5:00 PM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment goals?

2. In The Diabetes in Aging Study, which of the following was NOT among the top 3 most common nonfatal comorbidities that led experts to modify treatment goals in older patients?

3. At the time of diagnosis of diabetes, about how much beta-cell function is believed to be intact?

4. Which of the following is CORRECT about sliding-scale insulin?

5. If deciding to recommend the use of prandial insulin to intensify therapy in older patients, which of the following approaches would you choose to minimize the risk of hypoglycemia?

6. All of the following are features of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) EXCEPT:

7. All of the following are CORRECT regarding postprandial hyperglycemia EXCEPT:

8. Which of the following agents is NOT metabolized by the kidney and does not have dosing alterations in patients with renal impairment?

9. Which of the following is an example of a duplicative mechanism of action drug-drug interaction that should be brought to the attention of the prescribing clinician?

10. Which of the following is the most common cause of death for patients with T2DM that clinicians should be aware of when considering the adverse-effect profile of antihyperglycemic agents?

« Return to Activity

Maintenance is scheduled for 08/28/2024 6:00 AM EST - 08/28/2024 5:00 PM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment goals?

2. In The Diabetes in Aging Study, which of the following was NOT among the top 3 most common nonfatal comorbidities that led experts to modify treatment goals in older patients?

3. At the time of diagnosis of diabetes, about how much beta-cell function is believed to be intact?

4. Which of the following is CORRECT about sliding-scale insulin?

5. If deciding to recommend the use of prandial insulin to intensify therapy in older patients, which of the following approaches would you choose to minimize the risk of hypoglycemia?

6. All of the following are features of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) EXCEPT:

7. All of the following are CORRECT regarding postprandial hyperglycemia EXCEPT:

8. Which of the following agents is NOT metabolized by the kidney and does not have dosing alterations in patients with renal impairment?

9. Which of the following is an example of a duplicative mechanism of action drug-drug interaction that should be brought to the attention of the prescribing clinician?

10. Which of the following is the most common cause of death for patients with T2DM that clinicians should be aware of when considering the adverse-effect profile of antihyperglycemic agents?

« Return to Activity

Customers who Purchased
this Activity also Purchased